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OBLV60 is an acid-dependent syncytium-forming variant isolated from OBL21 cells persistently infected with the pH-
independent mouse hepatitis virus (MHV)-4 strain. The fusion activity of OBLV60 can be strictly regulated by controlling pH
and thus provides the means to definitively examine the entry of MHV into cells by endosomal and nonendosomal pathways.
Shortly after high multiplicity infection, both MHV-4 and OBLV60 were detected by electron microscopy in endosomal
vesicles and were recovered from lysates of cells treated with proteinase K to remove extracellular virus. For OBLV60, but
not MHV-4, exposure to lysosomotropic compounds early in infection prevented viral penetration and significantly reduced
viral yields. These results suggested that both MHV-4 and OBLV60 utilized the endosomal route of entry into cells, but that
MHV-4 did not require acidification of endosomal vesicles. Studies on the entry of virus through fusion at the cell surface
were performed by briefly exposing surface-bound OBLV60 to a fusion-permissive pH under conditions that prevent endocytic
entry. Acid treatment of surface-bound OBLV60 caused a significant increase in the yields of virus produced in cultures of
fusion-sensitive Sac0 or DBT cells, demonstrating entry of virus by fusion at the cell surface. No measurable increase in
virus production was detected with acid treatment of OBLV60 bound to OBL21 cells, suggesting that entry at the cell surface
does not occur in these cells, which are resistant to MHV-induced syncytia formation. These results raise interesting
questions concerning how mechanisms of MHV entry influence the selection of fusion variants. q 1997 Academic Press
INTRODUCTION type MHV strains can cause syncytium formation at neu-
tral pH; we have recently demonstrated that MHV-4-medi-
Enveloped viruses enter cells by fusing with cellular ated syncytium formation occurs independent of receptor
membranes. The site of this fusion event can be at the interactions (Nash and Buchmeier, 1996; Gallagher et al.,
cell surface or at the limiting membrane of endosomal 1992). Despite the fact that fusion of wild-type MHV is
vesicles following receptor-mediated endocytosis. Fu- pH-independent, direct evidence for MHV entry at the
sion is mediated by viral glycoproteins and it has hereto- cell surface has not been reported. Several reports have
fore been assumed that the route of entry is characteris- shown that polyethylene glycol (PEG)-facilitated entry of
tic of a given virus family as dictated by the pH optimum surface-bound MHV into cells led to productive infection
of fusion (reviewed by White, 1990). Paramyxoviridae and (Van Dinter and Flintoff, 1987; Flintoff and Van Dinter,
herpesviridae exhibit pH-independent fusion, and ultra- 1989; Kooi et al., 1991; Asanaka and Lai, 1993); PEG-
structural studies have shown viruses from these fami- facilitated entry of MHV was insensitive to inhibition by
lies entering at the cell surface. Orthomyxoviridae, togavi- lysosomotropic agents, which prevent endosomal acidifi-
ridae, and rhabdoviridae actively fuse only at acidic pH, cation (Kooi et al., 1991). These observations suggest
which is naturally encountered along the endocytic path- that, at least in some cell types, entry at the cell surface
way. Some acid-dependent viruses have been shown is sufficient for MHV internalization and that no specific
to fuse at the cell surface when the extracellular pH is endosomal factors are required for infection. Conversely,
artificially lowered (Helenius et al., 1980). It has recently it has been reported that MHV replication was delayed
been recognized that factors other than pH may influence or partially inhibited by lysosomotropic agents (Mallucci,
the route of viral entry. For example, some viruses require 1966; Krzystyniak and Dupuy, 1984; Mizzen et al., 1985;
additional factors, such as proteases, from the endoso- Kooi, 1991), suggesting that MHV entry occurs through
mal or extracellular environment (Scheid and Choppin, endocytosis. However, the inhibition of pH-independent
1976; Borrow and Oldstone, 1994). virus might be attributable to secondary effects of the
The pathway of entry for the murine coronavirus mouse lysosomotropic agents, which act on other acidic com-
hepatitis virus (MHV) has not been well defined. Wild- partments within the cell, or to a virucidal effect of ele-
vated pH.
In this report, we demonstrate that MHV-4 (JHM) can1 To whom correspondence and reprint requests should be ad-
utilize both endosomal and nonendosomal pathways fordressed at The Scripps Research Institute, Department of Neurophar-
entry into cells and that the pathway of entry dependsmacology, 10666 N. Torrey Pines Road (CVN-8), La Jolla, CA 92037.
Fax: (619) 784-7369. upon both the strain of virus and the nature of cell being
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infected. MHV fusion is mediated by the receptor-binding Sac0 Moloney sarcoma (Weiland et al., 1978) cell lines
were maintained in DMEM with 8% calf serum (Hyclone),spike (S) glycoprotein. The S glycoprotein resembles in-
fluenza hemagglutinin and the fusion proteins of several 25 mM HEPES, and 2 mM L-glutamine. OBL21, a retrovi-
rus-transformed neuronal cell line derived from the olfac-others viruses (reviewed by White, 1990) in that (i) it is
synthesized as a large precursor protein that is post- tory bulb of newborn CD1 mice (Ryder et al., 1990), was
maintained in DMEM with 10% fetal bovine serum (Irvinetranslationally cleaved into two subunits (Sturman et al.,
1985); (ii) the amino-terminal subunit, S1, contains the Scientific), 25 mM HEPES, and 2 mM L-glutamine.
receptor-binding site (Kubo et al., 1994); (iii) the mem-
Reagentsbrane-anchored, carboxy-terminal subunit, S2, contains
conserved regions of a-helical heptad repeats (deGroot Stock solutions (1001) of lysosomotropic agents were
et al., 1987) and the fusion-active domain (Gallagher et prepared as follows: 1 mM monensin (Calbiochem) in
al., 1991); and (iv) the glycoprotein forms oligomeric 100% ethanol, 5 mM chloroquine (Sigma) in distilled wa-
structures (Delmas and Laude, 1990) that extend from ter, and 50 mM bafilomycin A1 (Sigma) in DMSO. Stock
the surface of the virion or infected cell (Sturman et al., solutions (100 mM ) of the proteinase inhibitors phenyl-
1980). Unlike influenza hemagglutinin, cleavage of the methylsulfonyl fluoride (PMSF) and Pefabloc SC (Boeh-
MHV S does not expose an apparent canonical ‘‘fusion ringer Mannheim) were prepared in isopropanol and dis-
peptide’’ sequence of apolar amino acids (Holmes et al., tilled water, respectively.
1990) and cleavage increases fusogenicity (Frana et al.,
1985; Gombold et al., 1993), but is not absolutely required Plaque assays
(Stauber et al., 1993; Taguchi et al., 1993).
To measure the inhibitory effects of lysosomotropicIt has been previously reported that long-term persis-
agents on virus production, cells were treated with 10tent MHV-4 infection of a neuronal cell line (OBL21a) that
mM monensin, 50 mM chloroquine, or 500 nM bafilomycinis refractory to MHV-induced syncytium formation gave
for 1 hr before the addition of virus. Lysosomotropicrise to an acid-dependent fusion variant, OBLV60 (Gal-
agents were present throughout the course of the infec-lagher et al., 1991). MHV-4 and OBLV60 differ in their pH
tion unless otherwise indicated. Cells were infected at aoptimum for fusion due to three amino acid changes in
multiplicity of 1 plaque-forming unit per cell. In specifiedthe heptad repeat region of the S glycoprotein. Subse-
experiments, following adsorption of virus for 1 hr at 377,quent passage of OBLV60 in a cell line sensitive to MHV-
cells were exposed for 1, 2, or 5 min to MES-bufferedinduced syncytium formation (Sac0) led to the produc-
DMEM (pH 5.0). Viral titers at 12 or 16 hr postinoculation,tion of revertant viruses with restored neutral pH fusion
as indicated, were determined by plaque assay as pre-capability (Gallagher et al., 1991). Apparently, the selec-
viously described (Nash and Buchmeier, 1996).tive pressures exerted on MHV by cells resistant or sen-
To quantitate intracellular infectious virus, DBT cellssitive to syncytium formation led to the selection of pH-
were exposed to virus for 1 hr at 47, allowing viral attach-dependent or pH-independent variants. We hypothesized
ment, and were then incubated at 377 for 15 min, allowingthat, in cells resistant to syncytia formation, virus entry
internalization of bound virus. Cells were then treatedat the cell surface may be precluded and may thereby
with 0.5 mg/ml proteinase K for 45 min at 47 to removelead to selection of virus that efficiently enters by the
extracellular virus. The proteinase K reaction wasendocytic pathway; furthermore, in cells sensitive to syn-
stopped by addition of an equal volume of 4 mM PMSFcytia formation, pH-independent virus that is able to
or 20 mM Pefabloc SC with 6% bovine serum albumin inspread rapidly by cell–cell fusion may be favored. In the
PBS. The cells were washed, resuspended in RSB bufferpresent study, we examine the mechanism of entry of
(10 mM Tris, pH 7.4, 100 mM NaCl, 25 mM EDTA), andthe MHV-4 (pH-independent) and OBLV60 (pH-depen-
lysed by Dounce homogenization. The titer of virus re-dent) strains of MHV into cells that are susceptible or
leased was determined by standard plaque assay. Forresistant to MHV-induced syncytia formation, and we dis-
infectious center assays, following treatment with pro-cuss the selective advantages of pH-dependent and pH-
teinase inhibitor, cells were washed, serially diluted, thenindependent viruses in these cells.
seeded onto DBT cell monolayers in six-well plates. Fol-
lowing attachment of cells for 2 hr, the infectious centerMATERIALS AND METHODS
assays were processed as standard plaque assays.
Viral strains and cell lines
Electron microscopy
Strain MHV-4 was originally obtained from M. Haspel
(Haspel et al., 1978) and is routinely passaged in Sac0 Virus was adsorbed to DBT cells for 1 hr at 47, then
incubated at 377 for 15 min to allow internalization. Cellcells. The acid-dependent OBLV60 variant was isolated
on Day 60 of a persistent MHV-4 infection established were rinsed in cold PBS, fixed with modified Karnovsky’s
fixative (2% paraformaldehyde, 1.5% glutaraldehyde in 0.1in OBL21a cells (Gallagher et al., 1991).
DBT murine astrocytoma (Hirano et al., 1978) and M cacodylate buffer, pH 7.2) for 1 hr at 47, postfixed in
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TABLE 1
Inhibition of Virus Production by Lysosomotropic Agents
MHV-4 OBLV60
Sac0 DBT OBL21 Sac0 DBT OBL21
Untreated 4.70a 5.14 3.51 6.20 6.24 6.08
Chloroquine 3.70 (01.00)b 3.30 (01.84) 2.30 (01.21) 4.00 (02.18) 4.12 (02.12) 3.87 (02.99)
Monensin 2.99 (01.71) 3.08 (02.06) 1.38 (02.13) 3.20 (02.98) 2.42 (03.82) 2.98 (03.88)
Bafilomycin 3.16 (01.54) 2.95 (02.19) 1.78 (01.73) 3.15 (03.06) 2.93 (03.31) 3.11 (03.74)
a Log10 titer (PFU/ml).
b Change in log10 titer compared to untreated control.
1% OsO4 for 1 hr at room temperature, dehydrated in yields of OBLV60 harvested 12 hr after infection by 2.5
log10 in Sac0 or OBL21 cells, demonstrating that monen-graded ethanol, and embedded in lowicryl epon. Thin
sections were stained in uranyl acetate and lead citrate sin inhibited the entry of OBLV60, but not MHV-4. Addi-
tion of monensin after viral entry, from 1 to 6 hr or 6 toand viewed with a Hitachi HU-12A electron microscope.
12 hr after infection, affected the yield of MHV-4 and
OBLV60 to approximately the same degree (1–2 log10RESULTS
reduction), suggesting that this lysosomotropic agent
Effect of lysosomotropic agents on virus production acts late in infection on some viral or cellular factor that
is common to the replication pathways of these two viralAcid-dependent viruses enter cells through the endo-
strains. In this regard, it should be noted that monensincytic pathway and are inhibited by lysosomotropic agents
has been reported to inhibit both cleavage of S andthat prevent endosomal acidification (reviewed by Marsh
glycosylation of the matrix protein of MHV strain A59et al., 1989). We measured the inhibitory effects of lysoso-
(Niemann et al., 1982).motropic agents on the replication of MHV-4 and OBLV60
in Sac0, DBT, and OBL21 cells (Table 1). Three lysoso-
Endocytosis of MHV-4 and OBLV60 with inhibition ofmotropic agents with different mechanisms of action
OBLV60 penetration by lysosomotropic agentswere used: chloroquine, a weak base that accumulates
within vesicles; monensin, a carboxylic ionophore that
The observation that the entry of MHV-4 into cells wasdissipates the proton gradient across vesicle mem-
not inhibited by lysosomotropic agents does not rule outbranes; and bafilomycin A1, a specific, irreversible inhibi-
an endocytic route of entry for this virus; endocytosedtor of the vacuolar-ATPase proton pump that drives endo-
MHV-4 would have the capacity to fuse with the mem-somal acidification (Bowman et al., 1988). These lysoso-
branes of neutral vesicles. Because endocytosed virusmotropic agents strongly inhibited production of OBLV60
remains infectious until the time of uncoating (Heleniusin all three cell lines, reducing titers of virus harvested
et al., 1982), virus that is endocytosed can be distin-16 hr postinoculation by 2–4 log10 . The inhibition of the guished from virus that requires endosomal acidificationacid-dependent OBLV60 by lysosomotropic agents was
to penetrate from endosomes. Therefore, to assay fornot surprising; however, there was also a 1–2 log10 re- endocytosis of MHV, the amount of intracellular virusduction in the yields of MHV-4, despite the fact that MHV-
was measured shortly after infection from lysates of cells4 fusion is pH independent.
that have been treated with proteinase K to remove sur-
face-bound virus (Table 3). Cells were incubated withInhibition of virus by monensin at different times in
virus at 47 for 1 hr to allow virus to attach to the cellthe infection cycle
surface. In control experiments maintained at 47, protein-
ase K treatment reduced extracellular virus titers belowTo determine whether the lysosomotropic agents were
inhibiting virus entry or later stages of infection, we com- the limit of detection. Fifteen minutes after a shift to 377,
cells were treated with proteinase K and lysed. Bothpared the effect of the presence of monensin at various
times in the infection cycle (Table 2). The effects of mo- MHV-4 and OBLV60 were recovered from lysates of pro-
teinase K-treated cells, indicating that at least a portionnensin on MHV-4 and OBLV60 were a function of the
strain of virus and did not differ significantly between the of each inoculum was endocytosed. In the presence of
monensin or bafilomycin A1, there was an increase offusion-sensitive Sac0 cell line and the fusion-resistant
OBL21 cell line. The presence of monensin from 1 hr 1 log10 in the amount of intracellular virus recovered
from OBLV60-infected cells, demonstrating that when thebefore to 1 or 3 hr after infection did not significantly
affect MHV-4 titers (1 log10 reduction), but reduced the pH remained above its threshold for fusion, OBLV60 was
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TABLE 2
Effect of Monensin Treatment of Virus Production
Monensin treated
Virus strain Cell type Untreated 01 to 1 hr 01 to 3 hr 1 to 6 hr 6 to 12 hr 01 to 12 hr
MHV-4 Sac0 5.06a (00.82)b (00.96) (01.60) (02.23) (02.63)
MHV-4 OBL21 2.68 (00.92) (00.83) (01.24) (01.82) (01.45)
OBLV60 Sac0 5.89 (02.52) (02.89) (01.61) (02.07) (03.67)
OBLV60 OBL21 5.58 (02.47) (02.40) (02.24) (02.18) (04.01)
a Log10 titer (PFU/ml).
b Change in log10 titer compared to untreated control.
unable to exit from endosomal vesicles. The amount of tious center assays were performed on cells with or
without chloroquine or monensin, incubated with virusintracellular MHV-4 was unaffected by treatment with ly-
sosomotropic agents; therefore, MHV-4 was endocy- for 1 hr at 47 to allow attachment, shifted to 377 for 15
min, then treated with proteinase K to remove surface-tosed, but its exit from vesicles was not restricted when
endosomal acidification was prevented. These results bound virus (Table 4). The temporary presence of chlo-
roquine or monensin before and during internalizationwere supported by ultrastructural studies on DBT cells
fixed 15 min after infection with MHV-4 or OBLV60 (Fig. did not significantly affect the number of cells that were
infected with OBLV60 or MHV-4, demonstrating that entry1). In untreated cells infected with MHV-4 (Fig. 1A) or
OBLV60 (Fig. 1C), and also in monensin-treated cells of virus through the endosomal pathway led to produc-
tive infection.infected with MHV-4 (Fig. 1B), individual viral particles
were detected in small vesicles; however, the presence
Virus entry by fusion with the plasma membrane atof monensin (Fig. 1D) or chloroquine (data not shown) led
permissive pHto accumulation of OBLV60 virions in large endosomal
vesicles. To study the entry of MHV through direct fusion at the
cell surface, we took advantage of the fact that endocytic
Endosomal entry of MHV-4 and OBLV60 results in entry of OBLV60 can be blocked with lysosomotropic
productive infection agents and that OBLV60 fusion can be controlled by regu-
lating pH. With or without the presence of monensin,MHV has previously been observed within endosomal
surface-bound OBLV60 or MHV-4 was exposed to pH 5.0vesicles (David-Ferreira and Manaker, 1965); however,
for 1, 2, or 5 min, then returned to neutral pH (Fig. 2). Init has been suggested that endocytosed MHV may not
Sac0 cells, monensin treatment led to a 5 log10 reductionnecessarily be following a productive pathway (Kooi et
in OBLV60 titers and a 2.5 log10 reduction in MHV-4 titersal., 1991). The effects of chloroquine and monensin are
compared with untreated cultures. MHV-4 titers were notreversible (Maxfield, 1982); therefore, if the endosomal
significantly changed by acid treatment of surface-boundroute of entry is productive, OBLV60 infection should
virus; however, the 1-min acid pulse of surface-boundensue when these inhibitors of endosomal acidification
OBLV60 resulted in an increase in virus production ofare removed after internalization of virus. To demon-
greater than 1.5 log10 compared with monensin-treatedstrate whether infection proceeds when the lysosomo-
cultures held at neutral pH. Longer exposure to acidtropic agents are removed from the culture media, infec-
did not further increase virus production. These results
demonstrate that OBLV60 entered Sac0 cells through
TABLE 3 direct fusion at the cell surface when the extracellular
pH was permissive for fusion and therefore suggest thatIntracellular Infectious Virus in the Presence
the pH-independent MHV-4 is able to enter Sac0 cellsof Lysosomotropic Agents
through fusion at the cell surface under normal condi-
MHV-4 OBLV60 tions.
Untreated 4.55a 2.66 Failure of virus entry through fusion with the plasma
Chloroquine 4.47 (00.08)b 2.76 (/0.10)
membrane in cells resistant to syncytium formationMonensin 4.47 (00.08) 3.74 (/1.08)
Bafilomycin 4.46 (00.09) 3.60 (/0.94)
We have hypothesized that virus entry directly at the
cell surface may not occur in cells that are resistant toa Log10 titer (PFU/ml).
b Change in log10 titer compared to untreated control. MHV-induced cell–cell fusion. Infection with MHV-4 or
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FIG. 1. Electron micrograph demonstrating the inhibition of OBLV60 penetration by monensin. MHV-4 (A and B) or OBLV60 (C and D) was adsorbed
to the surface of untreated (A and C) or monensin-treated (B and D) DBT cells for 1 hr, incubated at 377 for 15 min to allow internalization of bound
virus, then fixed immediately and processed for electron microscopy. Individual viral particles in small vesicles are marked with thin arrows. Large
vesicles containing several OBLV60 particles are marked with thick arrows (D). Similar accumulation of virions in endosomal vesicles in cells
infected with OBLV60 was also observed in cells treated with chloroquine. Original magnification 30,0001 (A, B, and C) or 15,0001 (D).
expression of recombinant S glycoprotein does not lead
to syncytium formation in OBL21 cells; the resistance
of OBL21 cells to MHV-induced cell–cell fusion is not
overcome by acidic conditions (data not shown). To ex-
amine whether the nonendosomal pathway of viral entry
functions in these cells, surface-bound OBLV60 was ex-
posed to pH 5.0 for 1 min (Fig. 3). The presence of monen-
TABLE 4
Infectious Center Assay of Proteinase K-Treated Cells
MHV-4 OBLV60
Untreated 3.72a 3.51
Chloroquine 3.70 (00.02)b 3.80 (/0.29)
Monensin 3.80 (/0.08) 3.04 (00.47) FIG. 2. Acid treatment of surface-bound virus in the presence of
monensin. MHV-4 or OBLV60 attached to the surface of untreated or
monensin-treated Sac0 cells was exposed to pH 5 media for 1, 2, ora Log10 infectious centers/ml.
b Change in log10 infectious centers/ml compared to untreated control. 5 min. Viral titers were determined after a 16-hr incubation at 377.
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cytosis and the choice of entry pathways utilized can be
a function of the cell. Interestingly, Epstein–Barr virus
has also been shown to utilize both mechanisms of entry;
it entered epithelial cells through fusion at the cell sur-
face and B cells through the endocytic pathway (Miller
and Hutt-Fletcher, 1992).
The fact that the acid-dependent variant of MHV was
preferentially amplified in infected OBL21 cells suggests
that acid-activated virus has a selective advantage over
pH-independent virus in those cells for which viral entry
is restricted to the endocytic pathway, whereas the gen-
eration of revertant viruses in Sac0 cells implies that
acid-dependent virus is at a disadvantage in fusion-sen-
sitive cells. One major distinguishing feature betweenFIG. 3. Acid treatment of surface-bound OBLV60 on different cell
MHV infection of fusion-resistant and fusion-sensitivelines. OBLV60 attached to the surface of untreated or monensin-treated
DBT, Sac0, or OBL21 cells was exposed to pH 5 media for 1 min. cells is that there is a requisite extracellular stage for
Monensin was present either until 2 hr postinfection or throughout the virus dissemination among fusion-resistant cells as virus
16-hr infection as indicated. Viral titers were determined after a 16-hr released from one cell binds to receptor on the surface
incubation at 377.
of another cell and is then endocytosed. In contrast, in
fusion-sensitive cells, pH-independent virus can spread
rapidly through cell–cell fusion without being releasedsin for 1 hr before virus addition to 2 hr after virus internal-
from the cell or requiring further engagement with theization reduced the yields of OBLV60 harvested 16 hr
MHV receptor (Nash and Buchmeier, 1996; Gallagher etafter infection of DBT, Sac0, and OBL21 cells by 3.0, 2.4,
al., 1992). An extracellular stage in viral disseminationand 2.6 log10 , respectively, and the presence of monensin
would allow a greater opportunity for inactivation of viruscontinuously throughout the 16-hr infection reduced viral
and would therefore favor a more stable virus.yields by 6.5, 4.0, and 5.7 log10 , respectively. Whether
MHV is remarkably thermolabile (Sturman et al., 1990)monensin was present before and during internalization
and thermal inactivation of virus is accompanied by theor throughout the infection, acid treatment of surface-
disassembly of the S1–S2 spike glycoprotein complexbound virus led to an increase in OBLV60 production by
(Sturman et al., 1990; Weismiller et al., 1990). Due toDBT and Sac0 cells of 1 log10 ; however, exposure of
the thermolability of MHV-4, viral titers fluctuate in theOBLV60 attached to the surface of OBL21 cells to an
supernatant of persistently infected Sac0 or DBT cellacidic pulse did not measurably increase viral yields over
cultures. In contrast, Gallagher et al. (1991) reported thatthose of monensin-treated cultures maintained at neutral
viral titers continuously increased in the supernatant ofpH. Therefore, OBLV60 was unable to enter OBL21 cells
persistently infected OBL21 cell cultures. This observa-through fusion with the plasma membrane when condi-
tion suggested that virus produced by OBL21 cells mighttions were permissive for fusion.
be more thermostable than wild-type MHV-4. Subsequent
studies have demonstrated that OBLV60, the acid-depen-DISCUSSION
dent fusion variant that arose in persistently infected
OBL21 cells, is thermostable, whereas MHV-4 and theWe have examined the mechanism of MHV entry into
cells using a pair of isogenic MHV strains, the pH-inde- pH-independent fusion revertants are thermolabile
(Buchmeier et al., 1996). Furthermore, virion thermostabil-pendent MHV-4 strain and the acid-dependent OBLV60
strain. We demonstrated that both MHV-4 and OBLV60 ity correlated with stability of the spike glycoprotein
(Buchmeier et al., 1997). The mutations in the OBLV60productively infected cells through the endocytic path-
way; however, only OBLV60 required endosomal acidifi- spike glycoprotein apparently strengthen the S1–S2 in-
teraction at neutral pH and consequently increase ther-cation. When the pH was permissive for fusion, virus
also entered fusion-sensitive cells directly at the plasma mostability. Interestingly, Gombold et al. (1993) have
characterized fusion-defective variants of MHV-A59 thatmembrane; however, the direct fusion pathway for MHV
entry was not functional in the fusion-resistant OBL21 have impaired cleavage due to mutations in the S1–
S2 cleavage site. Like OBLV60, these fusion-defectivecell line. The reasons for the inherent fusion-resistance
of the OBL21 cell plasma membrane are not understood variants arose from persistent infections in cells that are
resistant to MHV-induced fusion, and subsequent pas-at this time. We conclude that OBLV60, because of its
requirement for acid activation of fusion, enters cells un- sage of the fusion-defective variants in a fusion-sensitive
cell line led to the production of fusion-competent re-der normal conditions only through the endocytic path-
way. In contrast, MHV-4 is capable of entering cells either vertants.
Marsh and Helenius (1989) discuss potential advan-through direct fusion at the cell surface or through endo-
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of the pH dependence of coronavirus-induced cell fusion: Effect oftages of viral entry through the endocytic pathway includ-
mutation in the spike glycoprotein. J. Virol. 65, 1916–1928.ing the insurance that virus is entering a metabolically
Gallagher, T. M., Buchmeier, M. J., and Perlman, S. (1992). Cell receptor-
active cell. Acid-activated viruses fuse faster and more independent infection by a neurotropic murine coronavirus. Virology
efficiently than pH-independent viruses, in part because 191, 517–522.
Gombold, J. L., Hingley, S. T., and Weiss, S. R. (1993). Fusion-defectivethere is a relatively synchronous activation of the fusion
mutants of mouse hepatitis virus A59 contain a mutation in the spikeproteins of an acid-dependent virus when the pH of the
protein cleavage signal. J. Virol. 67, 4504–4512.endosome drops below the relevant threshold. Addition-
Haspel, M. V., Lampert, P. W., and Oldstone, M. B. A. (1978). Tempera-
ally, endosomal factors may assist in uncoating of virus; ture sensitive mutants of mouse hepatitis virus produce a high inci-
it has been reported that the entry and uncoating of MHV dence of demyelination. Proc. Natl. Acad. Sci. USA 75, 4033–4036.
Helenius, A., Kartenbeck, J., Simons, K., and Fries, E. (1980). On the(JHM) requires at least two cellular factors other than the
entry of Semliki Forest virus into cells. J. Cell. Biol. 84, 404–420.MHV receptor, murine biliary glycoprotein (Asanaka and
Helenius, A., Marsh, M., and White, J. (1982). Inhibition of Semliki ForestLai, 1993; Yokomori et al., 1993). Furthermore, entry
virus penetration by lysosomotropic weak bases. J. Gen. Virol. 58,
through the endocytic pathway may ensure delivery of 47–61.
the viral genome deep within the cell (Marsh and Hele- Hirano, N., Goto, N., Makino, S., and Fujiwara, K. (1978). Utility of mouse
cell line DBT for propagation and assay of mouse hepatitis virus.nius, 1989). In some cases, entry of virus at the cell
Jpn. J. Exp. Med. 48, 71–75.surface does not lead to infection because viral nucleo-
Holmes, K. V., and Lai, M. M. C. (1996). Coronaviridae: The viruses andcapsids fail to reach cellular compartments required for
their replication. In ‘‘Virology’’ (Fields, B. Ed.), p. 1075. Lippincott-
viral replication (Matlin et al., 1982). Transport of virus to Raven, New York.
specific compartments within the cell may be especially Kooi, C., Cervin, M., and Anderson, R. (1991). Differentiation of acid-
pH-dependent and -nondependent entry pathways for mouse hepati-important in neurons and other cells with long cyto-
tis virus. Virology 180, 108–119.plasmic processes (Marsh and Helenius, 1989).
Krzystyniak, K., and Dupuy, J. M. (1984). Entry of mouse hepatitis virus
3 into cells. J. Gen. Virol. 65, 227–231.
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